Puede combinarse la retatrutida con otros pptidos en investigacin
These treatments reduce hunger, increase fullness, and optimize your bodys natural weight management processes
Patients received a 3-week treatment with dulaglutide (1.5 mg) or placebo (0.9% sodium chloride) subcutaneously once weekly and attended an 8-hour evaluation visit during the last treatment week
Mounjaro (branded as Zepbound for weight loss) is a slow-to-break-down version of both GLP-1 and the similar hormone GIP (glucose-dependent insulinotropic polypeptide)
Abbreviations ACEI: Angiotensin-converting enzyme inhibitors aHR: Adjusted hazard ratio AMI: Acute myocardial infarction ARB: Angiotensin II receptor blockers BMI: Body mass index CVD: Cardiovascular diseases CVOT: Cardiovascular outcome trial CI: Confidence interval CKD: Chronic kidney disease DM: Diabetes mellitus DPP-4i: Dipeptidyl peptidase-4 inhibitor eGFR: Estimated glomerular filtration rate ESKD: End-stage kidney disease GLP-1 RA: Glucagon-like peptide-1 receptor agonist HbA1c: Glycated hemoglobin HCOs: Healthcare organizations IQR: Interquartile range KTR: Kidney transplant recipient MACE: Major adverse cardiovascular events MAKE: Major kidney event PSM: Propensity score matching PTDM: Post-transplant diabetes mellitus RCTs: Randomized clinical trials SBP: Systolic blood pressure SD: Standard deviation SGLT2i: Sodium-glucose cotransporter 2 inhibitor SU: Sulfonylureas T2DM: Type 2 diabetes mellitus TZD: Thiazolidinediones References Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, et al
Retatrutide delivers approximately 28% more weight loss than tirzepatide at maximum doses (28.7% versus 22.5%)
